BROWN UNIVERSITY

Sammy Basso, a progeria patient and biologist, died at 28, known for his humor and advocacy. He participated in the first progeria drug trial and contributed to gene-editing research. Despite his condition, he lived with optimism and gratitude, influencing the scientific community and beyond.

Experts discussed AI's potential in Bhutan's healthcare, focusing on precision medicine, early diagnosis, remote monitoring, and drug discovery. Key points included AI for early disease detection, remote monitoring devices for rural areas, and the creation of a Biohub. The importance of infrastructure, human capital, data privacy, and integrating traditional medicine with modern practices was also highlighted.

The Katz School of Science and Health has added new faculty experts in AI, biotech, computer science, and digital marketing, enhancing its leadership in STEM education and research.

New research on nursing home care for Alzheimer’s patients found 13% received goal-discordant treatments, with hospital transfers and parenteral therapy most common. 87% received goal-concordant care, with hospice enrollment indicating comfort-based approaches. Study highlights challenges in measuring goal-concordant care and suggests future research to improve data collection.

URI President Marc Parlange celebrated URI's growth and successes, including top rankings and record applications, aligning with the Focus URI strategic plan. He highlighted new campus projects and the importance of Question 2 on the November ballot for higher education bonds. Parlange also recognized student, faculty, and staff achievements, emphasizing URI's commitment to making education attainable for all.

Johns Hopkins Medicine scientists found that 30 days in space weakened human bioengineered heart tissues, leading to reduced beating strength and irregular rhythms compared to Earth-bound samples. The study expands understanding of low gravity's effects on astronaut health and may aid in studying heart muscle aging and therapeutics on Earth.

Repare Therapeutics to present TRESR trial data on camonsertib monotherapy at ESMO Congress on Sept 14. The Phase 1/2 study aims to establish the recommended Phase 2 dose and evaluate safety, pharmacokinetics, and preliminary anti-tumor activity in patients with solid tumors.

Black stroke patients arrive at ERs 28 minutes later than white patients, increasing risk of death or disability. EMS is 20% less likely to notify hospitals ahead of Black patients' arrival, affecting treatment time. Delays are also seen in more deprived areas, highlighting systemic issues in EMS care.

Columbia University-led IndiPHARM project, funded by $39.5M from ARPA-H, aims to develop a platform measuring drugs, metabolites, and environmental factors to optimize therapeutic efficacy, reducing adverse drug events and improving patient care.

Joseph Edelman, Brown Corporation trustee and hedge fund manager, resigned publicly over Brown's upcoming divestment vote in October, citing concerns about antisemitism and Israel's destruction. Edelman, CEO of Perceptive Advisors, joined the board in 2019 and is a major donor to the University, funding research and human rights initiatives. His foundation has also donated to anti-trans advocacy groups.